Consensus BioAtla, Inc.

Equities

BCAB

US09077B1044

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
3.37 ^USD	+49.45%		+43.40%	+36.99%

03-27	HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating	MT
03-26	Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024

Evolution of the average Target Price on BioAtla, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a3f4b95810.aU6zcy4Lr2V1X83zNLcDFsuQB7rA_Rp0EF622q3gmfg.MRzfRBdY3R8iMf63Q_pXTqDnYOLyr34wfi-Bl-y69KsuAuJEXTvAJEBn_Q~e328c61d6f62217b4f18ca3f9fd6b8ff

Analyst Recommendations on BioAtla, Inc.

HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating	03-27	MT
HC Wainwright Lowers Price Target on BioAtla to $10 From $17, Maintains Buy Rating	11-08	MT
JPMorgan Adjusts BioAtla Price Target to $14 From $17, Maintains Overweight Rating	25/09/23	MT
JPMorgan Adjusts Price Target on BioAtla to $19 From $23, Maintains Overweight Rating	03/04/23	MT
JPMorgan Adjusts BioAtla's Price Target to $19 From $23, Keeps Overweight Rating	03/04/23	MT
BTIG Adjusts Price Target on BioAtla to $13 From $68, Maintains Buy Rating	28/03/23	MT
JMP Securities Adjusts Price Target on BioAtla to $12 From $17, Keeps Outperform Rating	27/03/23	MT
HC Wainwright Adjusts Price Target on BioAtla to $17 From $20, Keeps Buy Rating	24/03/23	MT
EF Hutton Initiates BioAtla at Buy With $25 Price Target	05/01/23	MT
Credit Suisse Raises BioAtla's Price Target to $8 From $4, Keeps Neutral Rating	04/11/22	MT
JMP Securities Starts BioAtla at Market Outperform With $17 Price Target	15/09/22	MT
HC Wainwright Adjusts BioAtla's Price Target to $20 from $25, Keeps Buy Rating	10/08/22	MT
Credit Suisse Downgrades BioAtla to Neutral from Outperform, Says Outlook On Key Assets Uncertain After Disappointing BA3011 Update; Lowers Price Target to $5 from $35	05/05/22	MT
HC Wainwright Starts BioAtla at Buy With $25 Price Target	21/03/22	MT
Credit Suisse Trims BioAtla's Price Target to $35 from $68, Maintains Outperform Rating	14/02/22	MT
BIOATLA : JPMorgan Adjusts BioAtla's Price Target to $64 from $62, Keeps Overweight Rating	18/08/21	MT
BIOATLA : Roth Capital Starts BioAtla at Buy With $75 Price Target	28/06/21	MT
BIOATLA : BTIG Adjusts Price Target on BioAtla to $87 From $47, Maintains Buy Rating	26/03/21	MT
BIOATLA : Credit Suisse Starts BioAtla at Outperform With $49 Price Target	11/01/21	MT
BIOATLA : BTIG Starts BioAtla at Buy With $47 Price Target	11/01/21	MT
BIOATLA : Jefferies Starts BioAtla at Buy With $51 Price Target	11/01/21	MT
BIOATLA : JPMorgan Starts BioAtla at Overweight With $45 Price Target	11/01/21	MT